Literature DB >> 21993306

Risk perception, risk management and safety assessment: what can governments do to increase public confidence in their vaccine system?

Noni E MacDonald1, Jennifer Smith, Mary Appleton.   

Abstract

For decades vaccine program managers and governments have devoted many resources to addressing public vaccine concerns, vaccine risk perception, risk management and safety assessment. Despite ever growing evidence that vaccines are safe and effective, public concerns continue. Education and evidence based scientific messages have not ended concerns. How can governments and programs more effectively address the public's vaccine concerns and increase confidence in the vaccine safety system? Vaccination hesitation has been attributed to concerns about vaccine safety, perceptions of high vaccine risks and low disease risk and consequences. Even when the public believes vaccines are important for protection many still have concerns about vaccine safety. This overview explores how heuristics affect public perception of vaccines and vaccine safety, how the public finds and uses vaccine information, and then proposes strategies for changes in the approach to vaccine safety communications. Facts and evidence confirming the safety of vaccines are not enough. Vaccine beliefs and behaviours must be shaped. This will require a shift in the what, when, how and why of vaccine risk and benefit communication content and practice. A change to a behavioural change strategy such as the WHO COMBI program that has been applied to disease eradication efforts is suggested.
Copyright © 2011. Published by Elsevier Ltd.. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21993306     DOI: 10.1016/j.biologicals.2011.08.001

Source DB:  PubMed          Journal:  Biologicals        ISSN: 1045-1056            Impact factor:   1.856


  27 in total

Review 1.  Live virus vaccines based on a vesicular stomatitis virus (VSV) backbone: Standardized template with key considerations for a risk/benefit assessment.

Authors:  David K Clarke; R Michael Hendry; Vidisha Singh; John K Rose; Stephen J Seligman; Bettina Klug; Sonali Kochhar; Lisa Marie Mac; Baevin Carbery; Robert T Chen
Journal:  Vaccine       Date:  2016-07-06       Impact factor: 3.641

Review 2.  Public trust and vaccine acceptance--international perspectives.

Authors:  Sachiko Ozawa; Meghan L Stack
Journal:  Hum Vaccin Immunother       Date:  2013-06-03       Impact factor: 3.452

3.  Evaluating vaccine avoidance from a wider angle.

Authors:  Melike Demirbag-Kaplan; Yusuf Cem Kaplan
Journal:  J Public Health Policy       Date:  2015-03-12       Impact factor: 2.222

4.  A systematic literature review to examine the potential for social media to impact HPV vaccine uptake and awareness, knowledge, and attitudes about HPV and HPV vaccination.

Authors:  Rebecca R Ortiz; Andrea Smith; Tamera Coyne-Beasley
Journal:  Hum Vaccin Immunother       Date:  2019-04-11       Impact factor: 3.452

Review 5.  Vaccine hesitancy: an overview.

Authors:  Eve Dubé; Caroline Laberge; Maryse Guay; Paul Bramadat; Réal Roy; Julie Bettinger
Journal:  Hum Vaccin Immunother       Date:  2013-04-12       Impact factor: 3.452

Review 6.  Strategies implemented to address vaccine hesitancy in France: A review article.

Authors:  Cécile Fokoun
Journal:  Hum Vaccin Immunother       Date:  2018-06-14       Impact factor: 3.452

Review 7.  Live virus vaccines based on a yellow fever vaccine backbone: standardized template with key considerations for a risk/benefit assessment.

Authors:  Thomas P Monath; Stephen J Seligman; James S Robertson; Bruno Guy; Edward B Hayes; Richard C Condit; Jean Louis Excler; Lisa Marie Mac; Baevin Carbery; Robert T Chen
Journal:  Vaccine       Date:  2014-10-27       Impact factor: 3.641

Review 8.  Is physician dismissal of vaccine refusers an acceptable practice in Canada? A 2018 overview.

Authors:  Noni E MacDonald; Shawn Harmon; Eve Dube; Beth Taylor; Audrey Steenbeek; Natasha Crowcroft; Janice Graham
Journal:  Paediatr Child Health       Date:  2018-10-01       Impact factor: 2.253

9.  The Brighton Collaboration Viral Vector Vaccines Safety Working Group (V3SWG).

Authors:  Robert T Chen; Baevin Carbery; Lisa Mac; Kenneth I Berns; Louisa Chapman; Richard C Condit; Jean-Louis Excler; Marc Gurwith; Michael Hendry; Arifa S Khan; Najwa Khuri-Bulos; Bettina Klug; James S Robertson; Stephen J Seligman; Rebecca Sheets; Anna-Lise Williamson
Journal:  Vaccine       Date:  2014-10-08       Impact factor: 3.641

10.  Vaccination status, acceptance, and knowledge toward a COVID-19 vaccine among healthcare workers: a cross-sectional survey in China.

Authors:  Xiao-Hong Li; Lin Chen; Qi-Ni Pan; Juan Liu; Xu Zhang; Jing-Jing Yi; Chun-Mei Chen; Qiu-Hu Luo; Pin-Yue Tao; Xiao Pan; Su-Yu Lu; Liang-Zhong Liu; Hui-Qiao Huang
Journal:  Hum Vaccin Immunother       Date:  2021-08-03       Impact factor: 4.526

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.